Mouse Anti-Influenza A, Nucleoprotein-UNLB

Cat. No.
10780-01  
Size
0.5 mg  
Price (USD)
$185.00 
Clone FluA-NP 4F1
Isotype Mouse (BALB/c) IgG1κ
Isotype Control Mouse IgG1-UNLB
Immunogen Recombinant influenza virus type A nucleoprotein
Specificity Influenza virus type A nucleoprotein
Alternalte Name(s) NP
Description Influenza virus type A nucleoprotein, also known as NP, is composed of a 498 amino acid sequence and is type-specific in influenza viruses. The NP encapsulates the virus genome to form a ribonucleoprotein (RNP) particle for the purposes of transcription and packaging. The monoclonal antibody FluA-NP 4F1 has been shown to specifically recognize type A influenza virus NP in virus infected cell culture and patient samples. This clone can be paired as a detection antibody for ELISA with clone FluA-NP 2C9 (SB Cat. No. 10770-01).
Format/Conjugate UNLB (Unconjugated)
Buffer Formulation Supplied in borate buffered saline, pH 8.2; No preservatives or amine-containing buffer salts added
Concentration 0.5 mg/mL
Volume 1.0 mL
Storage & Handling Store at 2-8°C
Please refer to product specific SDS
Applications
Applications for relevant formats of this clone include -
ELISA – Quality tested
Immunocytochemistry – Reported in literature 1-4,6,7
Western Blot – Reported in literature 2,4,5
Recommended Dilutions Please refer to product specific Technical Bulletin
  • Recombinant influenza proteins were resolved by electrophoresis, transferred to PVDF membrane, and probed with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01). Proteins were visualized using Goat Anti-Mouse IgG, Human ads-HRP (SB Cat. No. 1030-05) and with chemiluminescent detection.
  • MDCK cells infected with the influenza A (H1N1) virus were stained with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01) followed by a secondary antibody and DAPI.

    Image from Shoji M, Woo S, Masuda A, Win NN, Ngwe H, Takahashi E, et al. Anti-influenza virus activity of extracts from the stems of Jatropha multifida Linn. collected in Myanmar. BMC Complement Altern Med. 2017;17:96. Figure 3(a)
  • A549 cells infected with influenza H1N1 strain NC2 8 hours post infection were stained with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01) followed by an AF555 conjugated secondary antibody and DAPI.

    Image from Farooqui A, Leon AJ, Lei Y, Wang P, Huang J, Tenorio R, et al. Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice. Virol J. 2012;9:104. Figure 1(c)

Recombinant influenza proteins were resolved by electrophoresis, transferred to PVDF membrane, and probed with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01). Proteins were visualized using Goat Anti-Mouse IgG, Human ads-HRP (SB Cat. No. 1030-05) and with chemiluminescent detection.
 

MDCK cells infected with the influenza A (H1N1) virus were stained with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01) followed by a secondary antibody and DAPI.

Image from Shoji M, Woo S, Masuda A, Win NN, Ngwe H, Takahashi E, et al. Anti-influenza virus activity of extracts from the stems of Jatropha multifida Linn. collected in Myanmar. BMC Complement Altern Med. 2017;17:96. Figure 3(a)
 

A549 cells infected with influenza H1N1 strain NC2 8 hours post infection were stained with Mouse Anti-Influenza A, Nucleoprotein-UNLB (SB Cat. No. 10780-01) followed by an AF555 conjugated secondary antibody and DAPI.

Image from Farooqui A, Leon AJ, Lei Y, Wang P, Huang J, Tenorio R, et al. Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice. Virol J. 2012;9:104. Figure 1(c)
 
References
1. Wei G, Meng W, Guo H, Pan W, Liu J, Peng T, et al. Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein. PLoS One. 2011;6(12):e28309. (ICC)
2. Shoji M, Takahashi E, Hatakeyama D, Iwai Y, Morita Y, Shirayama R, et al. Anti-influenza activity of C60 fullerene derivatives. PLoS One. 2013;8(6):e66337. (ICC, WB)
3. Hatakeyama D, Shoji M, Yamayoshi S, Hirota T, Nagae M, Yanagisawa S, et al. A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication. J Biol Chem. 2014;289:24980-94. (ICC)
4. Shoji M, Arakaki Y, Esumi T, Kohnomi S, Yamamoto C, Suzuki Y, et al. Bakuchiol is a phenolic isoprenoid with novel enantiomer-selective anti-influenza A virus activity involving Nrf2 activation. J Biol Chem. 2015 Oct 7. pii: jbc.M115.669465. [Epub ahead of print]. (ICC, WB)
5. Narkpuk J, Wanitchang A, Kramyu J, Frantz PN, Jongkaewwattana A, Teeravechyan S. An unconventional BST-2 function: down-regulation of transient protein expression. Biochem Biophys Res Commun. 2014;450:1469-74. (WB)
6. Farooqui A, Leon AJ, Lei Y, Wang P, Huang J, Tenorio R, et al. Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice. Virol J. 2012;9:104. (ICC)
7. Shoji M, Woo S, Masuda A, Win NN, Ngwe H, Takahashi E, et al. Anti-influenza virus activity of extracts from the stems of Jatropha multifida Linn. collected in Myanmar. BMC Complement Altern Med. 2017;17:96. (ICC)